Status:
COMPLETED
Research on the Effectiveness and Safety of Remote Control of Domestic Surgical Robot System for Urinary Surgery
Lead Sponsor:
The Affiliated Hospital of Qingdao University
Conditions:
Renal Cell Carcinoma
Adrenal Tumor
Eligibility:
All Genders
18-65 years
Phase:
EARLY_PHASE1
Brief Summary
One-arm clinical trial was adopted in this study. The surgeon performed remote urological surgery for patients through domestically produced "MicroHand" surgical robot system (Shandong Weigao Co., Ltd...
Detailed Description
Objective： This clinical trial aims to evaluate the efficacy and safety of telesurgery for patients with tumors of the urinary system using Chinese independently developed "MicroHand" Surgical Robot S...
Eligibility Criteria
Inclusion
- ASA class I-III
- BMI: 18-30Kg/m2
- patients with Robson Stage I or II renal cell carcinoma that need radical nephrectomy
- patients with nonfunctioning kidney that need radical nephrectomy
- patients with adrenal tumor that need adrenalectomy
Exclusion
- women during pregnancy or lactation period
- patients with uncontrolled hypertension
- patients with a history of epilepsy or psychosis
- patients with severe cardiovascular disease (NYHA, grade III-IV)
- patients with cerebrovascular disease (CVD)
- patients with other diseases that cannot tolerate surgery
Key Trial Info
Start Date :
February 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT04804163
Start Date
February 27 2021
End Date
December 30 2021
Last Update
February 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China, 266003